Piper Sandler Downgrades Ardelyx to Neutral, Lowers Price Target to $4

Piper Sandler analyst Christopher Raymond downgrades Ardelyx (NASDAQ:ARDX) from Overweight to Neutral and lowers the price target from $14 to $4.

Piper Sandler analyst Christopher Raymond downgrades Ardelyx (NASDAQ:ARDX) from Overweight to Neutral and lowers the price target from $14 to $4.

Total
0
Shares
Related Posts